These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

830 related articles for article (PubMed ID: 17453514)

  • 1. Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation.
    Rappeport ED; Loft A; Berthelsen AK; von der Recke P; Larsen PN; Mogensen AM; Wettergren A; Rasmussen A; Hillingsoe J; Kirkegaard P; Thomsen C
    Acta Radiol; 2007 May; 48(4):369-78. PubMed ID: 17453514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of colo-rectal liver metastases: prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1.5 Tesla MR with extracellular and reticulo-endothelial cell specific contrast agents.
    Mainenti PP; Mancini M; Mainolfi C; Camera L; Maurea S; Manchia A; Tanga M; Persico F; Addeo P; D'Antonio D; Speranza A; Bucci L; Persico G; Pace L; Salvatore M
    Abdom Imaging; 2010 Oct; 35(5):511-21. PubMed ID: 19562412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of liver metastases from colorectal adenocarcinoma. Comparison of spiral-CTAP combined with intravenous contrast-enhanced spiral-CT and SPIO-enhanced MR combined with plain MR imaging.
    Strotzer M; Gmeinwieser J; Schmidt J; Fellner C; Seitz J; Albrich H; Zirngibl H; Feuerbach S
    Acta Radiol; 1997 Nov; 38(6):986-92. PubMed ID: 9394654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic metastases: detection with multi-detector row CT, SPIO-enhanced MR imaging, and both techniques combined.
    Onishi H; Murakami T; Kim T; Hori M; Iannaccone R; Kuwabara M; Abe H; Nakata S; Osuga K; Tomoda K; Passariello R; Nakamura H
    Radiology; 2006 Apr; 239(1):131-8. PubMed ID: 16484347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymph node metastasis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging versus PET/CT in a rabbit model.
    Choi SH; Moon WK; Hong JH; Son KR; Cho N; Kwon BJ; Lee JJ; Chung JK; Min HS; Park SH
    Radiology; 2007 Jan; 242(1):137-43. PubMed ID: 17090719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis.
    Ward J; Naik KS; Guthrie JA; Wilson D; Robinson PJ
    Radiology; 1999 Feb; 210(2):459-66. PubMed ID: 10207430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis.
    Reimer P; Jähnke N; Fiebich M; Schima W; Deckers F; Marx C; Holzknecht N; Saini S
    Radiology; 2000 Oct; 217(1):152-8. PubMed ID: 11012438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and characterization of liver metastases: 16-slice multidetector computed tomography versus superparamagnetic iron oxide-enhanced magnetic resonance imaging.
    Kim YK; Ko SW; Hwang SB; Kim CS; Yu HC
    Eur Radiol; 2006 Jun; 16(6):1337-45. PubMed ID: 16453115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
    Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
    Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging of small hepatic metastases of colorectal carcinoma: how to use superparamagnetic iron oxide-enhanced magnetic resonance imaging in the multidetector-row computed tomography age?
    Motosugi U; Ichikawa T; Nakajima H; Sou H; Sano M; Sano K; Araki T; Iino H; Fujii H; Nakazawa T
    J Comput Assist Tomogr; 2009; 33(2):266-72. PubMed ID: 19346857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small colorectal liver metastases: detection with SPIO-enhanced MRI in comparison with gadobenate dimeglumine-enhanced MRI and CT imaging.
    Hekimoglu K; Ustundag Y; Dusak A; Kalaycioglu B; Besir H; Engin H; Erdem O
    Eur J Radiol; 2011 Mar; 77(3):468-72. PubMed ID: 19781882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver metastases from colorectal cancer: imaging with superparamagnetic iron oxide (SPIO)-enhanced MR imaging, computed tomography and positron emission tomography.
    Rappeport ED; Loft A
    Abdom Imaging; 2007; 32(5):624-34. PubMed ID: 17710359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma in patients with chronic liver disease: comparison of SPIO-enhanced MR imaging and 16-detector row CT.
    Kim YK; Kwak HS; Kim CS; Chung GH; Han YM; Lee JM
    Radiology; 2006 Feb; 238(2):531-41. PubMed ID: 16371577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis--meta-analysis.
    Bipat S; van Leeuwen MS; Comans EF; Pijl ME; Bossuyt PM; Zwinderman AH; Stoker J
    Radiology; 2005 Oct; 237(1):123-31. PubMed ID: 16100087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US.
    Hagspiel KD; Neidl KF; Eichenberger AC; Weder W; Marincek B
    Radiology; 1995 Aug; 196(2):471-8. PubMed ID: 7617863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of MRI (including SS SE-EPI and SPIO-enhanced MRI) and FDG-PET/CT for the detection of colorectal liver metastases.
    Coenegrachts K; De Geeter F; ter Beek L; Walgraeve N; Bipat S; Stoker J; Rigauts H
    Eur Radiol; 2009 Feb; 19(2):370-9. PubMed ID: 18795299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of liver metastases from colorectal adenocarcinoma following chemotherapy: SPIO-MRI versus FDG-PET/CT.
    Bacigalupo L; Aufort S; Eberlé MC; Assenat E; Ychou M; Gallix B
    Radiol Med; 2010 Oct; 115(7):1087-100. PubMed ID: 20574703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and characterization of focal hepatic lesions: mangafodipir vs. superparamagnetic iron oxide-enhanced magnetic resonance imaging.
    Kim MJ; Kim JH; Lim JS; Oh YT; Chung JJ; Choi JS; Lee WJ; Kim KW
    J Magn Reson Imaging; 2004 Oct; 20(4):612-21. PubMed ID: 15390224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superparamagnetic iron oxide-enhanced MR imaging for focal hepatic lesions: a comparison with CT during arterioportography plus CT during hepatic arteriography.
    Tanimoto A; Wakabayashi G; Shinmoto H; Nakatsuka S; Okuda S; Kuribayashi S
    J Gastroenterol; 2005 Apr; 40(4):371-80. PubMed ID: 15870974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment.
    Niekel MC; Bipat S; Stoker J
    Radiology; 2010 Dec; 257(3):674-84. PubMed ID: 20829538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.